Data-integrity concerns in Europe at Teva & Interpharma raise the drug shortage versus quality debate
In June this year, PharmaCompass
was the first to report that Teva’s newly-built
sterile manuf
Mylan’s EpiPen price hike defense; India throws out plans of a bulk drug policy
This week, Phispers takes you through the EpiPen price hike controversy, and the Indian government&r
Compliance troubles emerge at Pfizer, Teva, Wockhardt and Xiamen Origin
It has been an
unprecedented week where compliance glitches have emerged from almost all parts
of t